King's College London

Research portal

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics)

Research output: Contribution to journalArticlepeer-review

Standard

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia : Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). / Poon, Liona C.; Magee, Laura A.; Verlohren, Stefan et al.

In: International Journal of Gynecology and Obstetrics, Vol. 154, No. S1, 07.2021, p. 3-31.

Research output: Contribution to journalArticlepeer-review

Harvard

Poon, LC, Magee, LA, Verlohren, S, Shennan, A, von Dadelszen, P, Sheiner, E, Hadar, E, Visser, G, Da Silva Costa, F, Kapur, A, McAuliffe, F, Nazareth, A, Tahlak, M, Kihara, AB, Divakar, H, McIntyre, HD, Berghella, V, Yang, H, Romero, R, Nicolaides, KH, Melamed, N & Hod, M 2021, 'A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics)', International Journal of Gynecology and Obstetrics, vol. 154, no. S1, pp. 3-31. https://doi.org/10.1002/ijgo.13763

APA

Poon, L. C., Magee, L. A., Verlohren, S., Shennan, A., von Dadelszen, P., Sheiner, E., Hadar, E., Visser, G., Da Silva Costa, F., Kapur, A., McAuliffe, F., Nazareth, A., Tahlak, M., Kihara, A. B., Divakar, H., McIntyre, H. D., Berghella, V., Yang, H., Romero, R., ... Hod, M. (2021). A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). International Journal of Gynecology and Obstetrics, 154(S1), 3-31. https://doi.org/10.1002/ijgo.13763

Vancouver

Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E et al. A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). International Journal of Gynecology and Obstetrics. 2021 Jul;154(S1):3-31. https://doi.org/10.1002/ijgo.13763

Author

Poon, Liona C. ; Magee, Laura A. ; Verlohren, Stefan et al. / A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia : Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). In: International Journal of Gynecology and Obstetrics. 2021 ; Vol. 154, No. S1. pp. 3-31.

Bibtex Download

@article{079ed4572bda49ccac3969fb27c7724c,
title = "A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics)",
keywords = "management, mean arterial pressure, monitoring, noncommunicable diseases, placental growth factor, pre-eclampsia, prediction, risk stratification, second trimester, soluble fms-like tyrosine kinase-1, third trimester, timed delivery, uterine artery pulsatility index",
author = "Poon, {Liona C.} and Magee, {Laura A.} and Stefan Verlohren and Andrew Shennan and {von Dadelszen}, Peter and Eyal Sheiner and Eran Hadar and Gerard Visser and {Da Silva Costa}, Fabricio and Anil Kapur and Fionnuala McAuliffe and Amala Nazareth and Muna Tahlak and Kihara, {Anne B.} and Hema Divakar and McIntyre, {H. David} and Vincenzo Berghella and Huixia Yang and Roberto Romero and Nicolaides, {Kypros H.} and Nir Melamed and Moshe Hod",
note = "Funding Information: This project was funded by unrestricted educational grants from PerkinElmer Inc., Waltham, USA; Roche Diagnostics International Ltd, Rotkreuz, Switzerland; and Thermo Fisher Scientific, Hennigsdorf, Germany. Funding Information: Relating to the submitted work, Liona Poon reports receipt of a Health and Medical Research Fund grant to assess the role of pro‐ and antiangiogenic markers for pre‐eclampsia in the second and third trimester (Project No: 136168059), and a grant from Roche Diagnostics for the Asia PROGNOSIS study. Outside the submitted work, LP reports honoraria for lectures from Roche Diagnostics, Ferring Pharmaceuticals, and GE Healthcare; nonfinancial support of in‐kind contributions for research from Roche Diagnostics, PerkinElmer Inc., Thermo Fisher Scientific, and GE Healthcare, and personal fees for consultancy from Roche Diagnostics and Ferring Pharmaceuticals. Outside the submitted work, Stefan Verlohren reports personal fees from Roche Diagnostics, Thermo Fisher Scientific, and Alexion. Outside the submitted work, Fabricio da Silva Costa reports research support from PerkinElmer Inc., and personal fees from Roche Diagnostics and Thermo Fisher Scientific. Outside the submitted work, Kypros H. Nicolaides reports being Director of the Fetal Medicine Foundation. All other authors report no actual or potential conflicts of interest. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = jul,
doi = "10.1002/ijgo.13763",
language = "English",
volume = "154",
pages = "3--31",
journal = "International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics",
issn = "1879-3479",
publisher = "Elsevier",
number = "S1",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia

T2 - Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics)

AU - Poon, Liona C.

AU - Magee, Laura A.

AU - Verlohren, Stefan

AU - Shennan, Andrew

AU - von Dadelszen, Peter

AU - Sheiner, Eyal

AU - Hadar, Eran

AU - Visser, Gerard

AU - Da Silva Costa, Fabricio

AU - Kapur, Anil

AU - McAuliffe, Fionnuala

AU - Nazareth, Amala

AU - Tahlak, Muna

AU - Kihara, Anne B.

AU - Divakar, Hema

AU - McIntyre, H. David

AU - Berghella, Vincenzo

AU - Yang, Huixia

AU - Romero, Roberto

AU - Nicolaides, Kypros H.

AU - Melamed, Nir

AU - Hod, Moshe

N1 - Funding Information: This project was funded by unrestricted educational grants from PerkinElmer Inc., Waltham, USA; Roche Diagnostics International Ltd, Rotkreuz, Switzerland; and Thermo Fisher Scientific, Hennigsdorf, Germany. Funding Information: Relating to the submitted work, Liona Poon reports receipt of a Health and Medical Research Fund grant to assess the role of pro‐ and antiangiogenic markers for pre‐eclampsia in the second and third trimester (Project No: 136168059), and a grant from Roche Diagnostics for the Asia PROGNOSIS study. Outside the submitted work, LP reports honoraria for lectures from Roche Diagnostics, Ferring Pharmaceuticals, and GE Healthcare; nonfinancial support of in‐kind contributions for research from Roche Diagnostics, PerkinElmer Inc., Thermo Fisher Scientific, and GE Healthcare, and personal fees for consultancy from Roche Diagnostics and Ferring Pharmaceuticals. Outside the submitted work, Stefan Verlohren reports personal fees from Roche Diagnostics, Thermo Fisher Scientific, and Alexion. Outside the submitted work, Fabricio da Silva Costa reports research support from PerkinElmer Inc., and personal fees from Roche Diagnostics and Thermo Fisher Scientific. Outside the submitted work, Kypros H. Nicolaides reports being Director of the Fetal Medicine Foundation. All other authors report no actual or potential conflicts of interest. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/7

Y1 - 2021/7

KW - management

KW - mean arterial pressure

KW - monitoring

KW - noncommunicable diseases

KW - placental growth factor

KW - pre-eclampsia

KW - prediction

KW - risk stratification

KW - second trimester

KW - soluble fms-like tyrosine kinase-1

KW - third trimester

KW - timed delivery

KW - uterine artery pulsatility index

UR - http://www.scopus.com/inward/record.url?scp=85111684274&partnerID=8YFLogxK

U2 - 10.1002/ijgo.13763

DO - 10.1002/ijgo.13763

M3 - Article

AN - SCOPUS:85111684274

VL - 154

SP - 3

EP - 31

JO - International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

JF - International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

SN - 1879-3479

IS - S1

ER -

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454